Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 12, 2009
Treatment of PTLD with rituximab and CHOP reduces the risk of renal graft impairment after reduction of immunosuppressionR Trappe, C Hinrichs, U Appel, et al.
Leukemia|September 27, 2008
The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG)C Buske, E Hoster, M Dreyling, et al.
Leukemia|March 24, 2020
Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trialsO Al-Sawaf, S Robrecht, J Bahlo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 19, 2014
A comprehensive analysis of the cellular and EBV-specific microRNAome in primary CNS PTLD identifies different patterns among EBV-associated tumorsS E K Fink, M K Gandhi, J P Nourse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2017
Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphomaM Dreyling, F Morschhauser, K Bouabdallah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 26, 2013
Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma NetworkC Y Cheah, A George, E Giné, et al.
Leukemia|December 2, 2015
Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locusE Leich, E Hoster, M Wartenberg, et al.
ESMO Open|March 10, 2022
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert ConsensusC Buske, M Dreyling, A Alvarez-Larrán, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2017
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)A Younes, P Hilden, B Coiffier, et al.
Pageof 5